This compound is primarily utilized in the field of pharmaceuticals as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its stereochemistry makes it valuable in the development of enantiomerically pure drugs, particularly those targeting the central nervous system. It is often employed in the preparation of compounds with potential therapeutic effects on neurological disorders, such as depression, anxiety, and schizophrenia. Additionally, its piperazine structure is beneficial in designing molecules with improved bioavailability and receptor selectivity. The dihydrochloride form enhances its solubility, making it suitable for formulation in aqueous-based drug delivery systems.